Removing a tumour and any possible metastases completely whilst preserving healthy tissue requires precision work down to the millimetre. Tumours labelled with fluorescent dyes, which can be visualised under short-wavelength infrared light, would make navigation during surgery much easier, as the tumours stand out much more clearly. Furthermore, this technique can also be used to make selected tissues, blood vessels and bodily fluids glow in a targeted manner. In addition to the necessary technology (suitable cameras), dyes suitable for fluorescence are required. An international team of researchers has now focused on the further development of cyanine dyes, which are among the most commonly used dyes for multicolour fluorescence microscopy. These are usually administered intravenously and can be linked, for example, to antibodies that bind specifically to tumours. The research team has now succeeded in developing two new dyes that are particularly well visualised under short-wavelength infrared light. They are non-toxic, water-soluble and can be coupled with biomolecules to target specific structures within the body. Together with an already approved dye (indocyanine green), three different dyes are now available for visualising tissue. In this way, tumours can now be visualised in blue, lymphatic vessels in green and blood vessels in magenta. The dyes and the imaging system have already been successfully tested in preclinical studies. The aim now is to further optimise the properties of the dyes so that, for example, they are easier to produce and can be coupled even more effectively with various biomolecules. Reference: National Cancer Institute, Bethesda; Helmholtz Centre, Munich. Targeted multicolour in vivo imaging over 1,000 nm enabled by nonamethine cyanines, Nature Methods 2022; https://rdcu.be/cHVTz
#cancer #tumour #oncology #fluorescentdyes #fluorescentimaging #tumoursurgery #imaging #medicine #medimpressions